SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Syngene International Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
539268 INE398R01022 104.1404189 SYNGENE 1.84 27,320.18 57.42 11.82 10
Quarters :
ParticularsMar 2024(Rs.Cr)Dec 2023(Rs.Cr)Sep 2023(Rs.Cr)
Gross Sales864.70791.90830.70
Other Operating Income0.000.000.00
Other Income 15.3028.8021.00
Total Income880.00820.70851.70
Total Expenditure 565.40596.10621.50
PBIDT314.60224.60230.20
Interest 8.506.308.60
PBDT306.10218.30221.60
Depreciation95.7093.6090.90
Tax41.5019.1022.80
Fringe Benefit Tax0.000.000.00
Deferred Tax-20.905.806.30
Reported Profit After Tax189.8099.80101.60
Extra-ordinary Items 0.00-2.96-5.75
Adjusted Profit After Extra-ordinary item189.80102.76107.35
    
EPS (Unit Curr.)4.732.492.53
EPS (Adj) (Unit Curr.)4.732.492.53
Calculated EPS (Unit Curr.)4.722.482.53
Calculated EPS (Adj) (Unit Curr.)4.722.482.53
Calculated EPS (Ann.) (Unit Curr.)18.899.9310.11
Calculated EPS (Adj) (Ann.) (Unit Curr.)18.899.9310.11
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity402.00402.00402.00
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)36.3828.3627.71
PBDTM(%)35.4027.5726.68
PATM(%)21.9512.6012.23